TY - JOUR T1 - Digitizing ECG image: new fully automated method and open-source software code JF - medRxiv DO - 10.1101/2021.07.13.21260461 SP - 2021.07.13.21260461 AU - Julian D. Fortune AU - Natalie E. Coppa AU - Kazi T. Haq AU - Hetal Patel AU - Larisa G. Tereshchenko Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/07/16/2021.07.13.21260461.abstract N2 - Background We aimed to develop and validate an automated, open-source code ECG-digitizing tool and assess agreements of ECG measurements across three types of median beats, comprised of digitally recorded, simultaneous and asynchronous ECG leads and digitized asynchronous ECG leads.Methods We used the data of clinical studies participants (n=230; mean age 30±15 y; 25% female; 52% had the cardiovascular disease) with available both digitally recorded and printed on paper and then scanned ECGs, split into development (n=150) and validation (n=80) datasets. The agreement between ECG and VCG measurements on the digitally recorded time-coherent median beat, representative asynchronous digitized, and digitally recorded beats was assessed by Bland-Altman analysis.Results Agreement between digitally recorded and digitized representative beat was high [area spatial ventricular gradient (SVG) elevation bias 2.5(95% limits of agreement [LOA] -7.9-13.0)°; precision 96.8%; inter-class correlation [ICC] 0.988; Lin’s concordance coefficient ρc 0.97(95% confidence interval [CI] 0.95-0.98)]. Agreement between digitally recorded asynchronous and time-coherent median beats was moderate for area-based VCG metrics (spatial QRS-T angle bias 1.4(95%LOA -33.2-30.3)°; precision 94.8%; ICC 0.95; Lin’s concordance coefficient ρc 0.90(95%CI 0.82-0.95)], but poor for peak-based VCG metrics of global electrical heterogeneity.Conclusions We developed and validated an open-source software tool for paper-ECG digitization. Asynchronous ECG leads are the primary source of disagreement in measurements on digitally recorded and digitized ECGs.Competing Interest StatementThe authors have declared no competing interest.Clinical Trialthis is a secondary data analysisFunding StatementThis work was partially supported by the National Institutes of Health (HL118277), Medical Research Foundation of Oregon, and OHSU President Bridge funding to Tereshchenko.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All studies were approved by the OHSU Institutional Review Board, and all participants signed informed consent before entering the study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe algorithm and open-source software code, written in Python (Python Software Foundation, Delaware, US), are provided at https://github.com/Tereshchenkolab/paper-ecg. https://github.com/Tereshchenkolab/paper-ecg ER -